NCT05710185View on ClinicalTrials.gov

Deucravacitinib for the Treatment of Palmoplantar Pustulosis

PHASE4RecruitingINTERVENTIONAL
Enrollment

18

Participants

Timeline

Start Date

July 1, 2023

Primary Completion Date

December 1, 2025

Study Completion Date

June 1, 2026

Conditions
Palmoplantar Pustulosis
Interventions
DRUG

Deucravacitinib

See arm/group description

Trial Locations (2)

19104

RECRUITING

University of Pennsylvania, Philadelphia

02115

RECRUITING

Brigham and Women's Hospital, Boston

All Listed Sponsors
collaborator

University of Pennsylvania

OTHER

lead

Brigham and Women's Hospital

OTHER